Pharsight

Drugs that contain Pralatrexate

1. Folotyn patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6028071 ACROTECH BIOPHARMA Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors
Jul, 2022

(1 year, 10 months ago)

US8299078 ACROTECH BIOPHARMA Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin
May, 2025

(a year from now)

US7622470 ACROTECH BIOPHARMA Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin
May, 2025

(a year from now)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE) Sep 24, 2016
New Chemical Entity Exclusivity(NCE) Sep 24, 2014

NCE-1 date: 24 September, 2013

Market Authorisation Date: 24 September, 2009

Treatment: Treatment of patients with relapsed or refractory peripheral t-cell lymphoma

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of FOLOTYN before it's drug patent expiration?
More Information on Dosage

FOLOTYN family patents

Family Patents